Curaleaf Holdings annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Curaleaf Holdings Stock-Based Compensation Growth & History (CURLF)
Curaleaf Holdings's stock-based compensation was $35.7M for fiscal 2025.
View full Curaleaf Holdings company overviewCuraleaf Holdings annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $35.7M | $10.0M | +39.07% |
| 2024 | 2024-12-31 | $25.7M | $5.7M | +28.42% |
| 2023 | 2023-12-31 | $20.0M | −$8.0M | −28.58% |
| 2022 | 2022-12-31 | $28.0M | −$11.5M | −29.04% |
| 2021 | 2021-12-31 | $39.5M | $8.6M | +27.86% |
| 2020 | 2020-12-31 | $30.9M | $14.3M | +85.94% |
| 2019 | 2019-12-31 | $16.6M | — | — |
Curaleaf Holdings quarterly stock-based compensation
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $10.3M | $1.8M | +21.16% |
| Q1 2026 | 2026-03-31 | $9.7M | — | — |
| Q4 2025 | 2025-12-31 | $12.3M | — | — |
| Q3 2025 | 2025-09-30 | $10.3M | — | — |
| Q2 2025 | 2025-06-30 | $8.5M | — | — |
Curaleaf Holdings stock-based compensation trends
Over the last five fiscal years, Curaleaf Holdings's stock-based compensation increased from $30.9M to $35.7M, a change of $4.9M. The latest reported quarter, Q2 2026, shows $10.3M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Curaleaf Holdings source filings ↗